Company intelligence / Profile preview

Verogen

San Diego, California, United States

Ownership: Private
Employees: ~57
Development stage: Other

Overview

Verogen's NGS-based forensic identification solutions, including the ForenSeq workflow and GEDmatch platform, are deployed in forensic and human identification labs globally to enable advanced analysis such as kinship, STRs, mtDNA, and phenotype prediction for unresolved and complex cases[1][5].

Industry: Molecular Diagnostics

Partnerships

Illumina (technology platform prior to acquisition by QIAGEN)

Beyond the preview

Go deeper on Verogen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verogen.

Explore the full profile